Title:
ENPP1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/197987
Kind Code:
A1
Abstract:
Disclosed are a novel compound as represented by formula (I-b) having an ENPP1 inhibitory activity, a pharmaceutical composition comprising the compound, an intermediate useful for preparing the compound, and a method for treating cell proliferative diseases, such as tumors, by using the above-mentioned compound.
Inventors:
YAN QI (CN)
PAN JIANFENG (CN)
SUN DAQING (CN)
PAN JIANFENG (CN)
SUN DAQING (CN)
Application Number:
PCT/CN2023/087272
Publication Date:
October 19, 2023
Filing Date:
April 10, 2023
Export Citation:
Assignee:
SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD (CN)
International Classes:
A61K31/4188; C07D407/14; A61K31/4745; A61K31/675; A61P35/00
Domestic Patent References:
| WO2022125614A1 | 2022-06-16 | |||
| WO2019177971A1 | 2019-09-19 | |||
| WO2021061803A1 | 2021-04-01 |
Foreign References:
| CN111372587A | 2020-07-03 | |||
| CN113677350A | 2021-11-19 |
Download PDF: